Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

The biofilm inhibitor Carolacton inhibits planktonic growth of virulent pneumococci via a conserved target.

Donner J, Reck M, Bergmann S, Kirschning A, Müller R, Wagner-Döbler I.

Sci Rep. 2016 Jul 11;6:29677. doi: 10.1038/srep29677.

3.

Twenty Years of Active Bacterial Core Surveillance.

Langley G, Schaffner W, Farley MM, Lynfield R, Bennett NM, Reingold A, Thomas A, Harrison LH, Nichols M, Petit S, Miller L, Moore MR, Schrag SJ, Lessa FC, Skoff TH, MacNeil JR, Briere EC, Weston EJ, Van Beneden C.

Emerg Infect Dis. 2015 Sep;21(9):1520-8. doi: 10.3201/eid2109.141333.

4.

Emerging Infections Program as Surveillance for Antimicrobial Drug Resistance.

Fridkin SK, Cleveland AA, See I, Lynfield R.

Emerg Infect Dis. 2015 Sep;21(9):1578-81. doi: 10.3201/eid2109.150512.

5.

The Mysteries of Streptococcal Pharyngitis.

Martin JM.

Curr Treat Options Pediatr. 2015 Jun;1(2):180-189. No abstract available.

6.

Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in Chinese healthy population aged >2 years: A randomized, double-blinded, active control, phase III trial.

Kong Y, Zhang W, Jiang Z, Wang L, Li C, Li Y, Xia J.

Hum Vaccin Immunother. 2015;11(10):2425-33. doi: 10.1080/21645515.2015.1055429.

7.

Antimicrobial Susceptibility Pattern of Invasive Pneumococcal Isolates in North West Nigeria.

Lliyasu G, Habib AG, Mohammad AB.

J Glob Infect Dis. 2015 Apr-Jun;7(2):70-4. doi: 10.4103/0974-777X.154440.

8.

Antimicrobial susceptibility trends among Streptococcus pneumoniae over an 11-year period in an Iranian referral children Hospital.

Haghi Ashtiani MT, Sadeghian M, Nikmanesh B, Pourakbari B, Mahmoudi S, Mamishi S.

Iran J Microbiol. 2014 Dec;6(6):382-6.

9.

Phenotypic and functional analysis of HL-60 cells used in opsonophagocytic-killing assay for Streptococcus pneumoniae.

Kim KH, Seoh JY, Cho SJ.

J Korean Med Sci. 2015 Feb;30(2):145-50. doi: 10.3346/jkms.2015.30.2.145. Epub 2015 Jan 21.

10.

Antimicrobial Susceptibilities and Distribution of Resistance Genes for β-Lactams in Streptococcus pneumoniae Isolated in Hamadan.

Najafi Mosleh M, Gharibi M, Alikhani MY, Saidijam M, Kalantarian G.

Jundishapur J Microbiol. 2014 Oct;7(10):e12714. doi: 10.5812/jjm.12714. Epub 2014 Oct 1.

11.

Antimicrobial susceptibility and analysis of macrolide resistance genes in Streptococcus pneumoniae isolated in Hamadan.

Mosleh MN, Gharibi M, Alikhani MY, Saidijam M, Vakhshiteh F.

Iran J Basic Med Sci. 2014 Aug;17(8):595-9.

12.

Changes in pneumococcal serotypes and antimicrobial resistance after introduction of the 13-valent conjugate vaccine in the United States.

Richter SS, Diekema DJ, Heilmann KP, Dohrn CL, Riahi F, Doern GV.

Antimicrob Agents Chemother. 2014 Nov;58(11):6484-9. doi: 10.1128/AAC.03344-14. Epub 2014 Aug 18.

13.

Invasive pneumococcal disease after implementation of 13-valent conjugate vaccine.

Iroh Tam PY, Madoff LC, Coombes B, Pelton SI.

Pediatrics. 2014 Aug;134(2):210-7. doi: 10.1542/peds.2014-0473. Epub 2014 Jul 7.

14.

A novel protein, RafX, is important for common cell wall polysaccharide biosynthesis in Streptococcus pneumoniae: implications for bacterial virulence.

Wu K, Huang J, Zhang Y, Xu W, Xu H, Wang L, Cao J, Zhang X, Yin Y.

J Bacteriol. 2014 Sep;196(18):3324-34. doi: 10.1128/JB.01696-14. Epub 2014 Jul 7.

15.

Changes in capsule and drug resistance of Pneumococci after introduction of PCV7, Japan, 2010-2013.

Chiba N, Morozumi M, Shouji M, Wajima T, Iwata S, Ubukata K; Invasive Pneumococcal Diseases Surveillance Study Group.

Emerg Infect Dis. 2014 Jul;20(7):1132-9. doi: 10.3201/eid2007.131485.

16.

Evidence for soft selective sweeps in the evolution of pneumococcal multidrug resistance and vaccine escape.

Croucher NJ, Chewapreecha C, Hanage WP, Harris SR, McGee L, van der Linden M, Song JH, Ko KS, de Lencastre H, Turner C, Yang F, Sá-Leão R, Beall B, Klugman KP, Parkhill J, Turner P, Bentley SD.

Genome Biol Evol. 2014 Jun 10;6(7):1589-602. doi: 10.1093/gbe/evu120.

17.

Factors associated with ceftriaxone nonsusceptibility of Streptococcus pneumoniae: analysis of South African national surveillance data, 2003 to 2010.

von Mollendorf C, Cohen C, de Gouveia L, Quan V, Meiring S, Feldman C, Klugman KP, von Gottberg A.

Antimicrob Agents Chemother. 2014 Jun;58(6):3293-305. doi: 10.1128/AAC.02580-13. Epub 2014 Mar 31.

18.

High-dose amoxicillin with clavulanate for the treatment of acute otitis media in children.

Chu CH, Wang MC, Lin LY, Tu TY, Huang CY, Liao WH, Ho CY, Shiao AS.

ScientificWorldJournal. 2014 Jan 6;2013:965096. doi: 10.1155/2014/965096. eCollection 2013.

19.

Serotyping of Streptococcus pneumoniae isolated from Tehran by Multiplex PCR: Are serotypes of clinical and carrier isolates identical?

Mousavi SF, Nobari S, Rahmati Ghezelgeh F, Lyriai H, Jalali P, Shahcheraghi F, Oskoui M.

Iran J Microbiol. 2013 Sep;5(3):220-6. Erratum in: Iran J Microbiol. 2014 Feb;6(1):59.

20.

From knock-out phenotype to three-dimensional structure of a promising antibiotic target from Streptococcus pneumoniae.

Dogovski C, Gorman MA, Ketaren NE, Praszkier J, Zammit LM, Mertens HD, Bryant G, Yang J, Griffin MD, Pearce FG, Gerrard JA, Jameson GB, Parker MW, Robins-Browne RM, Perugini MA.

PLoS One. 2013 Dec 13;8(12):e83419. doi: 10.1371/journal.pone.0083419. eCollection 2013.

Items per page

Supplemental Content

Write to the Help Desk